These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9685890)
1. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids. Takahata H; Lavelle EC; Coombes AG; Davis SS J Control Release; 1998 Jan; 50(1-3):237-46. PubMed ID: 9685890 [TBL] [Abstract][Full Text] [Related]
2. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Lavelle EC; Yeh MK; Coombes AG; Davis SS Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157 [TBL] [Abstract][Full Text] [Related]
3. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Delgado A; Lavelle EC; Hartshorne M; Davis SS Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065 [TBL] [Abstract][Full Text] [Related]
4. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098 [TBL] [Abstract][Full Text] [Related]
5. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers. Yeh MK; Davis SS; Coombes AG Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336 [TBL] [Abstract][Full Text] [Related]
6. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles. Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169 [TBL] [Abstract][Full Text] [Related]
7. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin. Cho SW; Song SH; Choi YW Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588 [TBL] [Abstract][Full Text] [Related]
8. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. O'Hagan DT; Jeffery H; Davis SS Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845 [TBL] [Abstract][Full Text] [Related]
9. The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. Coombes AG; Yeh MK; Lavelle EC; Davis SS J Control Release; 1998 Mar; 52(3):311-20. PubMed ID: 9743451 [TBL] [Abstract][Full Text] [Related]
10. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles. Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429 [TBL] [Abstract][Full Text] [Related]
11. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Coombes AG; Lavelle EC; Jenkins PG; Davis SS Vaccine; 1996 Oct; 14(15):1429-38. PubMed ID: 8994318 [TBL] [Abstract][Full Text] [Related]
12. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. Gasper MM; Blanco D; Cruz ME; Alonso MJ J Control Release; 1998 Mar; 52(1-2):53-62. PubMed ID: 9685935 [TBL] [Abstract][Full Text] [Related]
13. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Yeh MK J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles. Dutt M; Khuller GK J Antimicrob Chemother; 2001 Jun; 47(6):829-35. PubMed ID: 11389115 [TBL] [Abstract][Full Text] [Related]
15. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres. Barman SP; Lunsford L; Chambers P; Hedley ML J Control Release; 2000 Dec; 69(3):337-44. PubMed ID: 11102674 [TBL] [Abstract][Full Text] [Related]
16. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802 [TBL] [Abstract][Full Text] [Related]
18. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. Singh M; Shirley B; Bajwa K; Samara E; Hora M; O'Hagan D J Control Release; 2001 Jan; 70(1-2):21-8. PubMed ID: 11166404 [TBL] [Abstract][Full Text] [Related]
19. Controlled release microparticles for vaccine development. O'Hagan DT; Jeffery H; Roberts MJ; McGee JP; Davis SS Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495 [TBL] [Abstract][Full Text] [Related]
20. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids. Ghaderi R; Artursson P; Carlfors J Eur J Pharm Sci; 2000 Mar; 10(1):1-9. PubMed ID: 10699378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]